drugset / Trial / NCT00543413

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)

NCT00543413

Phase 2 Completed 160 enrolled Merck Sharp & Dohme LLC Actelion · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effectiveness and tolerability of MK8141 in lowering blood pressure in patients who have hypertension (high blood pressure).

Timeline

Start
2007-10
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enalapril Other / unclassified 20 mg
Subject MK8141 Unknown 250 mg
Subject MK8141 Unknown 500 mg

Indications